Celebrating 10 Years of Trusted News Discovery
One News Page
> > >

Blood pressure drug recall: Teva pulls losartan tablets tainted with possible carcinogen Thursday, 13 June 2019
Teva Pharmaceuticals has expanded its recall of losartan potassium tablets that contained a possible carcinogen

Recent related videos from verified sources

FDA Expands Recall Of Multiple Blood Pressure Medications [Video]FDA Expands Recall Of Multiple Blood Pressure Medications

Torrent Pharmaceuticals Limited has expanded its recall for Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets for all consumers. Katie Johnston reports.

Credit: CBS Dallas Digital     Duration: 00:34Published

Blood Pressure Drug Recall Expanded [Video]Blood Pressure Drug Recall Expanded

The FDA is expanding a recall of blood pressure medications.

Credit: WBZ CBS Boston     Duration: 00:18Published

You Might Like

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2019 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.